🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The Phase I trial is evaluating safety, tolerability, pharmacokinetics and ...
Status
Recruiting
Location
Herlev and Gentofte Hospital, Center for Cancer Research
Start Date
2021-04-12
Trial ID
NCT04855435
Treatments Being Tested
This is a Phase 1/2 study of the combination of Ad-p53 administered intra-a...
Status
Terminated
Location
MD Anderson Cancer Center
Start Date
2018-11-20
Trial ID
NCT02842125
The purpose of this first-in-human study is to evaluate the safety, tolerab...
Status
Recruiting
Location
City of Hope National Medical Center
Start Date
2025-07-31
Trial ID
NCT07094113
Treatments Being Tested
This multi-institutional, phase 2 clinical trial is studying two doses of p...
Status
Completed
Location
Mayo Clinic
Start Date
2017-01
Trial ID
NCT02818920
Treatments Being Tested
The purpose of this study is to determine safety and preliminary efficacy o...
Status
Recruiting
Location
University of California at San Diego Moores Cancer Center
Start Date
2024-04-22
Trial ID
NCT06385080
Treatments Being Tested
This phase I/II trial studies the side effects of pembrolizumab and vorinos...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2015-10-08
Trial ID
NCT02538510
Treatments Being Tested
This study consists of Part A for monotherapy and Part B for combination th...
Status
Recruiting
Location
NEXT Oncology
Start Date
2021-12-02
Trial ID
NCT05204862
Treatments Being Tested
This phase Ib trial studies the side effects of pembrolizumab and trametini...
Status
Completed
Location
University of California Davis Comprehensive Cancer Center
Start Date
2018-06-26
Trial ID
NCT03299088
Treatments Being Tested
This is a phase II, single arm, open-label, interventional trial of pembrol...
Status
Terminated
Location
Istituto Ortopedico Rizzoli
Start Date
2017-05-30
Trial ID
NCT03013127
Treatments Being Tested
This study is a Phase I/II, multicenter, first-in-human, open-label dose-es...
Status
Active Not Recruiting
Location
Sarah Cannon Research Institute at HealthONE
Start Date
2020-07-17
Trial ID
NCT04561362
Treatments Being Tested